Ailin — Seed (estimated) · €1.5M

Ailin, which sells at-home clinical test kits paired with software that interprets the results, closed its first funding round of €1.5M backed by public and private investors, with no lead disclosed. Participants included CDTI through the Neotec programme, Decelera Ventures, a healthcare-focused family office, two impact funds and several business angels.